GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
GLP-1 receptor (GLP-1R) is widely located throughout the brain, but the precise molecular mechanisms mediating the actions of GLP-1 and its long-acting analogs on adipose tissue as well as the brain areas responsible for these interactions remain largely unknown. We found that central injection of a clinically used GLP-1R agonist, liraglutide, in mice stimulates brown adipose tissue (BAT) thermogenesis and adipocyte browning independent of nutrient intake. The mechanism controlling these actions is located in the hypothalamic ventromedial nucleus (VMH), and the activation of AMPK in this area is sufficient to blunt both central liraglutide-induced thermogenesis and adipocyte browning. The decreased body weight caused by the central injection of liraglutide in other hypothalamic sites was sufficiently explained by the suppression of food intake. In a longitudinal study involving obese type 2 diabetic patients treated for 1 year with GLP-1R agonists, both exenatide and liraglutide increased energy expenditure. Although the results do not exclude the possibility that extrahypothalamic areas are also modulating the effects of GLP-1R agonists, the data indicate that long-acting GLP-1R agonists influence body weight by regulating either food intake or energy expenditure through various hypothalamic sites and that these mechanisms might be clinically relevant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Beiroa (36) et al. injected GLP-1 analog, liraglutide (LIR), into mice. LIR was found to stimulate the thermogenesis of brown adipose tissue and the browning of adipose cells, independent of the intake of nutrients. It can increase the thermogenesis and utilization of triacylglycerol-derived fatty acids and glucose in brown adipocytes and reduce the lipid content through the central GLP-1R agonist”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [36]
In the citing paper
“Nevertheless, the results showed reduced or unaltered REE in both studies after treatment with GLP-1 Ras, as opposed to the first studies, where GLP-1 RAs led to a raised REE, mainly when adjusted for fat-free mass [101].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [101]
In the citing paper
“Furthermore, a central injection of liraglutide in mice stimulated thermogenesis of BAT and browning of white adipocytes independently of nutrient intake [176].”
From Dysregulated epicardial adipose tissue as a risk factor and potential therapeutic target of heart failure with preserved ejection fraction in diabetes (2022) · cites this paper as [176]
In the citing paper
“In particular, feeding activates the secretion of periprandial gut hormones, such as CCK, GLP‐1, or secretin 105, 106, 107.”
From Inter‐organ communication: a gatekeeper for metabolic health (2019) · cites this paper as [105]
Citations
Cites
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Wu, J., Boström, P., Sparks, L. M., Ye, L., Choi, J. H., Giang, A.-H., Khandekar, M., Virtanen, K. A., Nuutila, P., Schaart, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.016 · Cited by 3,319
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950 · cited 4×
“In agreement with previous findings (7,17,18), we found that the central stimulation of GLP-1R reduces food intake and body weight.”
BackgroundResultInfluentialGlucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundBuse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503 · cited 9×
“In addition to the functional data on liraglutide from the mouse study, we analyzed data from a cohort of obese patients with T2D who had been treated for 1 year with the antidiabetic drugs metformin and metformin in combination with the GLP-1R agonists exenatide and liraglutide (Table 1).”
BackgroundInfluentialPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500 · cited 1×
“Among its numerous physiological effects (3), GLP-1 increases insulin and decreases glucagon secretion in a glucose-dependent manner (4,5), slows gastric emptying (6), increases glucose disposal, and decreases appetite (7).”
BackgroundAstrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Garber, A., Henry, R., Ratner, R., Garcia-Hernandez, P. A., Rodriguez-Pattzi, H., Olvera-Alvarez, I., Hale, P. M., Zdravkovic, M., & Bode, B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61246-5 · Cited by 1,057
Cited by
Items 501–598 of 598
Jazmin Osorio, M., Mitchell, S. E., Hambly, C., Allison, D. B., & Speakman, J. R. (2024) · Appetite · doi:10.1016/j.appet.2024.107421 · Cited by 3
“…may also involve cholecystokinin (CCK) and glucagon-like peptide 1 (GLP-1) which stimulate the efferent tone of sympathetic innervation in BAT and activate meal associated non-shivering thermogenesis (Beiroa et al., 2014; Blouet & Schwartz, 2012), but in this case indirectly via the brain.”
BackgroundChondronikola, M., & Sidossis, L. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-52031-5_6 · Cited by 2
CCK Response Deficiency in Synphilin-1 Transgenic Mice
Smith, W. W., Smith, M., Yang, D., Choi, P. P., Moghadam, A. A., Li, T., & Moran, T. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142314 · Cited by 2
“Central or peripheral administration of long-acting GLP-1 agonists reduces food intake and leads to weight loss in diabetic rodents and humans [19,31].”
BackgroundBrown Adipose Tissue and Body Weight Regulation
Freemark, M., & Collins, S. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_7 · Cited by 2
Šumarac-Dumanović, M. (2017) · Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · doi:10.5937/medgla1767009s · Cited by 2
Medikamentöse Adipositastherapie – Chancen und Perspektiven
Lautenbach, A., Aberle, J., Meyhöfer, S. M., & Meyhöfer, S. (2021) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-1491-5805 · Cited by 3
“Weiterhinhatsich herausgestellt, dass auch GLP-1 die Aktivierung und Thermogenese von BAT unabhängig von der Nahrungsaufnahme stimulieren kann.DerMechanismus,derdieseWirkungsteuert,befindetsich dabei im hypothalamischen ventromedialen Kern [44].”
BackgroundInfluentialTschöpe, C., Elsanhoury, A., Nelki, V., Linthout, S. V., Kelle, S., & Remppis, A. (2021) · Der Internist · doi:10.1007/s00108-021-01182-y · Cited by 3
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., Koehler, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522509 · Cited by 2
Mitochondrial Function and Dysfunction in White Adipocytes and Therapeutic Implications
Wang, F., Huynh, P. M., & An, Y. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230009 · Cited by 10
Sun, X., Yin, Y., Song, M., Droz, B. A., LIN, Y., Beaty, K. N., Zhou, B., Roh, H. C., Wilson, J. M., Cain, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.18.695152 · Cited by 2
Mamontova, E. D., Michurina, S. S., Стафеев, Ю. С., Sorkina, E., Скляник, И. А., Koksharova, E., Menshikov, M., Shestakova, M. V., & Парфёнова, Е. В. (2021) · Biochemistry (Moscow) · doi:10.31857/s032097252103009x · Cited by 1
Obesity and Atrial Fibrillation: Therapeutic Perspective for GLP-1 Analogs
Szołkiewicz-Płatkowska, A., & Orczykowski, M. (2024) · In a good rythm · doi:10.5604/01.3001.0054.6436 · Cited by 1
Enhanced thermogenesis in PAS Kinase-deficient male mice
Hurtado-Carneiro, V., Juan-Arévalo, Y., Flores, C. N., Herrero-de-Dios, C. M., Pérez-García, A., Contreras, C., López, M., Álvarez, E., & Sanz, C. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116757 · Cited by 1
Intestinal Epithelial-Derived Exosomes Under Cold Stimulation Promote Adipose Thermogenesis
Han, X., Feng, T., Yang, Y., Zhu, Z., Shao, F., Sun, L., Yin, Y., & Zhang, W. (2025) · Metabolites · doi:10.3390/metabo15050324 · Cited by 1
Correra, A., Mauriello, A., Cetoretta, V., Maratea, A. C., Riegler, L., Sarno, I. D., Giallauria, F., Guerra, F., Russo, V., & D’Andrea, A. (2026) · Pharmaceuticals · doi:10.3390/ph19020297 · Cited by 3
Hypothalamic wars: the last nanodelivery
Fazal, S., Vattathara, J. J., & López, M. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10022-z · Cited by 1
Fueling or Fighting Cancer? The Thermogenic Paradox of Brown Adipose Tissue
Guerrero, J. J. G., Encarnacion, P. C., Wang, C., del Rosario, M. A. S., Notarte, K. I., Zhou, J., Hsieh, Y.-T., Wang, W.-Y., Chang, C.-W., & Li, W.-C. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00699-3 · Cited by 2
“Activation of GLP-1R in the hypothalamus enhances sympathetic nervous system activity, leading to increased BAT thermogenesis and the induction of adipose browning through an AMPK-dependent mechanism [ 142 , 143].”
Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
Baragetti, A., & Norata, G. D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70483 · Cited by 1
Xie, J., Yang, Y., Chen, W., (45927), L. W., Weng, S., Lyu, Q., & Cao, G. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00722-7 · Cited by 1
“The GLP-1R agonist liraglutide, when administered centrally, promotes brown adipose tissue thermogenesis and white adipose browning via inhibition of AMPK in the VMH [141].”
The central amygdala gates exogenous glucagon-like peptide 1 signals
Duran, M., Zeng, N., Cutts, E. J., POLAMARASETTY, A., Rodríguez, M., Habegger, K. M., & Hardaway, J. A. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102403 · Cited by 2
Falahee, B. E., Apovian, C. M., & Istfan, N. W. (2026) · Obesity · doi:10.1002/oby.70294 · Cited by 1
Extra Glycemic Impacts of GLP-1 Receptor Agonists: Benefits of a Class Effect?
Araújo, L. M. D. M., Feguri, S., de Oliveira, T. L., Pedrosa, F. B., Guimarães, R. G., de Sá, L. B. P. C., Rocha, D. R. T. W., & Arbex, A. K. (2016) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2016.61007 · Cited by 2
Nutrient Sensors Regulating Peptides
Çakır, I., & Nillni, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_6 · Cited by 1
Targeting the Epicardial Adipose Tissue
Iacobellis, G. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-40570-0_15 · Cited by 1
Pi, Y., Du, T. T., & Zhao, P. (2022) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.976 · Cited by 1
“While decreasing food consumption may account for some of the causes of weight reduction, yes GLP-1 analogues have been found to impact energy metabolism[17].”
BackgroundPharmacotherapeutic options for the management of obesity in children
Aldhafiri, A. J. (2023) · Journal of advanced Biomedical and Pharmaceutical Sciences · doi:10.21608/jabps.2023.225432.1194 · Cited by 1
Yu, H., Feng, N., Zhong, W., Han, Y., Cheng, Y., Zhang, Z., Wang, Y., Gao, P., Huang, R., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402546r · Cited by 2
FAcTs on fire: Exploring thermogenesis
Rodríguez-Díaz, A., Diéguez, C., López, M., & Freire-Agulleiro, Ó. (2025) · Advances in genetics · doi:10.1016/bs.adgen.2025.02.002 · Cited by 2
Fatty Acids and Hypothalamic Dysfunction in Obesity
Pimentel, G. D., Contreras, C., & López, M. (2016) · Elsevier eBooks · doi:10.1016/b978-1-63067-036-8.00021-4 · Cited by 2
GLP1-Receptor Agonists in Diabetes: Drugs, General Effects, and Cardiovascular Impact
Breder, I. S. S., & Sposito, A. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_51 · Cited by 1
Entwicklung und Regulation des braunen Fettgewebes
Tews, D., & Wabitsch, M. (2022) · Springer eBooks · doi:10.1007/978-3-662-59216-8_13 · Cited by 1
Iacobellis, G. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15904 · Cited by 1
Sivayoganathan, T. (2018) · TSpace (University of Toronto) · Cited by 1
Castellá, M., & Villarroya, F. (2023) · Medicina Clínica · doi:10.1016/j.medcli.2023.02.002 · Cited by 1
Self-citationCastellá, M., & Villarroya, F. (2023) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2023.02.007 · Cited by 2
Self-citationKooijman, A., van den Heuvel, J. K., & Rensen, P. C. N. (2015)
General Discussion and Future Perspectives
Cassarini, C. (2019) · CRC Press eBooks · doi:10.1201/9780429448300-7
A new long-acting GLP-1 derivative 6- KTP ameliorates body weight and lipid metabolism in DIO micePreprint
Wang, P., & Ran, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/846717
Farr, S. (2017) · TSpace (University of Toronto)
Taher, J. (2017) · TSpace (University of Toronto) · Cited by 1
Efeito da interleucina 17 na regulação hipotalâmica da homeostase energética
Nogueira, G. A. S. (2019) · doi:10.47749/t/unicamp.2019.1157283
Efeito do sistema incretínico sobre o recrutamento de adipócitos bege
Oliveira, F. C. B. (2018) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2018.02.t.32242
Drug-induced metabolic alterations in adipose tissue - with an emphasis in epicardial adipose tissue
Pinho, A. C. O., Burgeiro, A., Pereira, M. J., & Carvalho, E. (2022) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202220201819
Regional Intestinal Drug Absorption
Gonzalez-Alvarez, M. I., & Dahan, A. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-3657-6
Horváth, T. L., & Miletta, M. C. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736481047.793567170
Kanamarlapudi, V. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734616040.793572407
Суплотова, Л. А., Fedorova, A. I., Kulmametova, D. S., Сергеевна, Д. Т., & Makarova, O. B. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-23-148-155
Beslenmenin Merkezi ve Periferal Regülasyonu
KESKİN, E., & GEZGİÇ, B. (2023) · doi:10.59287/sbyc.543
Alhusayni, K. M., Aljuaid, A. M., Alkhammash, A. M., Alzahrani, S. A., Alorabi, A. K., Alotaibi, Y. B., Alhumaidi, N. T., Alharbi, W. K., Harbi, G. A., & Alzahrani, I. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.11735
“In addition, through the GLP-1 receptors in the CNS, GLP-1RAs may influence peripheral glucose metabolism [10]. c. Regulate food intake and energy utilization Animal studies have shown that GLP-1RAs’ central activation of GLP-1 receptors induces brown adipose tissue thermogenesis and white adipose…”
BackgroundGLP-1 Secretion Induced by Dietary Proteins and Peptides, and Its Hypoglycemic and Thermic Effects
Hira, T. (2024) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.77.13
GLP-1RA Promotes Beige Differentiation in Adipose Tissue
刘, 臻. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143795
The evolving role of GLP-1 agonists in ischemic stroke prevention in diabetic patients
Shankar, A., Sharma, A., Buch, C. A., & CHILTON, R. J. (2024) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000308
“…glucose-mediated insulin release from beta cells of the pancreas [7], decreasing glucose production potentially by its action on alpha cells [7] Also, by regulating food intake and energy expenditure by the effect on brown adipose tissue metabolism [8] and by delaying gastric emptying [9].”
BackgroundThe glucagon-like peptide-1 (GLP-1) drugs poised to conquer obesity
Yin, J., Liu, Y., & Jia, W. (2024) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-0417
Bonner, C., Saponaro, C., Imbernón, M., Louvet, I., Deligia, E., Chen, S., Davies, I., Acosta-Montalvo, A., Moreno-Lopez, M., Wemelle, E., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-5544620/v1
Self-citationBrown or beige adipose tissue – a target for metabolic health therapy?
Тучина, Т. П., Kononova, Y. A., Георгиевич, З. Г., & Babenko, A. Y. (2025) · Russian Journal for Personalized Medicine · doi:10.18705/2782-3806-2025-5-1-6-28
Introduction to Obesity and Anti-obesity Medications
Garcha, S. C., & Kalra, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1651-0_1
Zhang, Z., Liu, S., Xian, J., Zhang, Y., Zhang, C., Wang, Z., Deng, H., Feng, J., & Yao, L. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm26154
“…various indirect mechanisms, such as inhibiting the renin–angiotensin system to lower blood pressure and regulate myocardial mitochondrial function [100], altering substrate delivery of fatty acids and glucose to the heart [11], suppressing inflammation by regulating the expression of inflammatory…”
Modder, M., Tomás, A., Afkir, S., Pronk, A. C. M., Streefland, T. C. M., Lalai, R. A., van Eenige, R., Rensen, P. C. N., Jones, B. J., & Kooijman, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16374
“47 We suspect GLP-1 receptor signalling bias, as identified in pancreatic β -cells, to be less relevant in neuronal populations, a phenomenon known as tissue bias, possibly partly explained by different levels of GLP-1 receptor expression in these different cell types.”
Shah, H., & Ayala, J. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666640
“Studies show that Glp1r agonists either increase [17-19] decrease [20, 21], or do not influence [8, 22-24] EE.”
Mehr als nur Wärme: Wie braunes Fettgewebe unsere Gefäße schützen könnte
Hollstein, T. (2025) · Aktuelle Kardiologie · doi:10.1055/a-2606-7053
Varra, F., Varras, M. N., Varra, V., & Theodosis‐Nobelos, P. (2025) · Current Clinical Pharmacology · doi:10.2174/0127724328392698250818071803 · Cited by 3
Autophagy in adipose tissue thermogenic function
Villarroya, J., Blasco-Roset, A., & Giralt, M. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.10.006
Neuroendocrine Control of Brown Adipocytes: Functions, Beiging, Whitening and AutophagyPreprint
Winne, C. D., Lopez-Vicchi, F., Boneo, L. E., Ornstein, A. M., Lacau-Mengido, I. M., Sorianello, E. M., & Becu-Villalobos, D. (2021) · Research Square · doi:10.21203/rs.3.rs-472876/v1
Omran, F., Murphy, A. M., Younis, A. Z., Kyrou, I., Vrbíková, J., Hainer, V., Šrámková, P., Fried, M., Ball, G., Tripathi, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22662434
Omran, F., Murphy, A. M., Younis, A. Z., Kyrou, I., Vrbíková, J., Hainer, V., Šrámková, P., Fried, M., Ball, G., Tripathi, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22662437
Navigating molecular targets: Plant nutraceuticals in the battle against obesity
Ramar, M., Riley, G. L., Laddha, A. P., & Velayutham, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31698-2.00017-5
Mihalache, L., & Graur, L. I. (2025) · Springer eBooks · doi:10.1007/978-3-032-11445-7_8 · Cited by 1
Host-mediated Remodeling of the Gut Microbiota in Energy Homeostasis and Environmental Resilience
Weng, Y.-H., Chen, P.-C., & Ruan, J. (2026) · Journal of physiological investigation. · doi:10.4103/ejpi.ejpi-d-25-00028
Inhibition of daily torpor in mice requires calories, not just feeding: a potential role for GLP-1
McLear, G. M., Kakarla, A. R., Taylor, C. E., & Swoap, S. J. (2026) · Journal of Comparative Physiology B · doi:10.1007/s00360-025-01649-6
“The role of GLP-1 in the regulation of thermogenesis has been examined, and most evidence suggests that GLP-1 increases energy expenditure and activates brown adipose tissue sympathetically (González-García et al. 2019 ; Lockie et al. 2012; Beiroa et al. 2014; O’Shea et al. 1996; Hwa et al. 1998).”
Low dose systemic AAV-exendin-4 gene therapy for Prader-Willi syndrome and dietary obesity
Huang, W., Xiao, M., Zou, X., Mohammed, T., Feng, Z., & Cao, L. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201718
“63 Rec2-Ex4 gene therapy increased BDNF receptor TrkB FL expression in the hypothalamus (Figure 5A).”
Kaynakci, E. C. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1794882
“In rodents, central GLP-1 receptor activation stimulates sympathetic outflow to adipose tissue, induces thermogenic gene programs, and promotes browning of white adipose depots (7, 8).”
Hypothalamus-liver talks: whispers in the language of metabolism
Ferreira, V., Fernández-González, I., Vattathara, J. J., Rodríguez-Díaz, A., Fernández-Sanmartín, P., & Diéguez, C. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10031-y
“Importantly, VMH AMPK activation blunts these effects, while the reduction in body weight caused by the central injection of liraglutide in other hypothalamic sites is sufficiently explained by food intake suppression [147].”
Moughaizel, M. (2020) · theses.fr (ABES) · doi:10.70675/d21b4f34z8e9az4348za233z7629490bce9e
Infections virales respiratoires et tissus adipeux blancs : Exemple de la grippe et de la COVID-19
Barthelemy, J. (2022) · theses.fr (ABES) · doi:10.70675/6439a82ez7179z48e3zbb8ez93846ae0ac14
The central amygdala integrates exogenous glucagon-like peptide 1 signalsPreprint
Duran, M., Zeng, N., Cutts, E. J., Habegger, K. M., & Hardaway, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.06.716705
McGuane, C., Farhadhar, N., Sharieff, K. A., Petrosky, S. N., & Alabasi, K. (2026) · Cureus · doi:10.7759/cureus.109731
Meng, Q., Xu, H., Zhong, M., Mu, Y., Zhao, X., Lin, C., Xu, F., Yang, M., Sun, H., Xu, Y., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19060852
Rajamoorthi, A., Hollingsworth, T., Guan, Y., Pinney, S. E., & Simmons, R. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.07.730723
“…have been reported in non-pregnant preclinical models, where GLP-1 receptor agonism enhances lipolytic and oxidative activity in white adipose tissue, reduces adipose inflammation, and promotes thermogenic and browning gene expression, in some studies, independent of nutrient intake (53-55).”
Khalifa, A. S., Ibrahim, A., Khalid, S., Abdelfattah, A. M., Bakkar, N. Z., Elrewiny, M. A., & El-Yazbi, A. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00021-8
Epicardial adipose tissue in cardiovascular diseases: a potential therapeutic target
Gong, Z., & Xiong, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1817940
“GLP1R agonists have the potential to target EAT GLP1Rs to decrease adipogenesis, enhance fat utilization, promote BAT differentiation, and modulate the renin – angiotensin – aldosterone system (112 – 114), thereby exhibiting cardioprotective effects.”
Saponaro, C., Imbernón, M., Louvet, I., Deligia, E., Chen, S., Davies, I., Acosta-Montalvo, A., Moreno-Lopez, M., Wemelle, E., Kothegala, L., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06779-2
“These benefits involve liraglutide’s action on hypothalamic areas and the brainstem [8, 9], suggesting broader impacts on metabolic pathways beyond direct pancreatic effects.”
Self-citationIncretins: From Gene Expression to Secretion and Action of GLP-1 and GIP
Lobato, C. B., & Holst, J. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00004-4
Rojas-Bergés, I., Villamil-Galván, R. M., Salgado-López, S., Obregón-Rosas, S., & Granados‐Montiel, J. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1824863 · Cited by 1
Piguet, C. E. M., Nucci, R., & Beaudry, J. L. (2026) · The Journal of Physiology · doi:10.1113/jp291081 · Cited by 1
Subedi, L., Bamjan, A. D., Kim, E., Phuyal, S., Sapkota, B., Kim, K.-T., Cho, S., Shim, J., Seo, J. B., & Park, J. W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115297
Jo, D., Song, D. J., Jeong, S. W., & Song, J. (2026) · Current Molecular Pharmacology · doi:10.1016/j.cmp.2026.09.011
Johnston, M. J., & Brown‐Borg, H. M. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_27-2
Erkan, İ. B. Ö., Senturk, L. M., Erel, C. T., Seyisoğlu, H., Şahmay, S., & Durmuşoğlu, F. (2026) · Climacteric · doi:10.1080/13697137.2026.2735765 · Cited by 1
El-Demerdash, A. S. (2026) · Medical Hypotheses · doi:10.1016/j.mehy.2026.112214
Smarkusz-Zarzecka, J., Radziszewska, M., Gofron, K. K., & Ostrowska, L. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10098-7 · Cited by 1
Mirmiranpour, H., & BARBER, T. M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1949288
Raffaelli, F., Oelkrug, R., Iwen, K. A., & Mittag, J. (2026) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.18885903
Glucagon-like Peptide-1 Receptor Agonists Promote Sympathetic Innervation in Mouse Adipose Tissues
Fu, K., Deng, Z., Wu, W., Yang, J. H., & Cao, Y. (2026) · Metabolites · doi:10.3390/metabo16110813
Metadata
- Authors
- Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., Dieguez, C., Lopez, M., Frühbeck, G., & Nogueiras, R.
- Affiliations
- Universidade de Santiago de Compostela (ES)
- Department of Physiology, CIMUS, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain
- Spanish National Cancer Research Centre (ES)
- Centro de Investigación Biomédica en Red (ES)
- University of Bergen (NO)
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-09-15
- Volume
- 63
- Issue
- 10
- Pages
- 3346-3358
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2108365604
- Cited by
- 602
- References
- 52
- Citations by year
- 2026: 42 · 2025: 63 · 2024: 60 · 2023: 51 · 2022: 57 · 2021: 59 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 43 · 2016: 49 · 2015: 41 · 2014: 8
- FWCI
- 31.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- GLP-1 receptor agonists, liraglutide, exenatide, brown adipose tissue thermogenesis, adipocyte browning, ventromedial hypothalamus, AMPK, energy expenditure, food intake regulation, body weight, obesity, type 2 diabetes, central nervous system
- MeSH terms
- Liraglutide, Exenatide, AMP-Activated Protein Kinase Kinases, Adult, Aged, Aged, 80 and over, Animals, Adipose Tissue, Brown, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Eating, Energy Metabolism, Female, Humans, Hypoglycemic Agents, Hypothalamus, Male, Metformin, Middle Aged, Obesity, Peptides, Protein Kinases, Venoms, Thermogenesis, Mice, Rats, Glucagon-Like Peptide 1, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.